Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 10, 2024 4:30 P.M.
Form: S-3
CIK: 0001678660
Company Name: Prelude Therapeutics Inc
File Number: 333-279829